Common side effects of ruxolitinib ointment

Ruxolitinib ointment (Opzelura ) is a topical medication used to treat atopic dermatitis and vitiligo. Although effective, like other medications, it may cause some side effects. Understanding these side effects can help patients identify and address potential problems during treatment.

The most common side effects include local skin reactions. Many patients may experience redness, swelling, itching, or burning sensations on the affected skin after using ruxolitinib ointment. These reactions are usually mild and gradually resolve with continued use of the medication. However, if these symptoms persist or worsen, you should contact your doctor for evaluation.

In addition, ruxolitinib ointment may cause skin dryness and irritation, which is particularly common in people with atopic dermatitis. To alleviate these symptoms, patients can use moisturizers with the advice of their doctor. Also, while using ruxolitinib ointment, patients should avoid using other topical medications or chemicals that may aggravate skin irritation.

Because ruxolitinib is a JAKinhibitor, it may have effects on the immune system. In some rare cases, use of ruxolitinib ointment may increase the risk of infection, such as localized skin infection or systemic infection. Patients should be monitored closely for signs of infection during treatment, such as fever, pus on the skin, or sudden worsening of symptoms. If these conditions occur, seek medical attention immediately.

Other less common side effects may include skin discoloration, abnormal hair growth, or skin atrophy. In rare cases, ruxolitinib ointment may also cause more severe immune system suppression, leading to a decrease in red blood cells, white blood cells, or platelets in the blood, which are often associated with systemic use of JAKinhibitors.

In general, although ruxolitinib ointment (Opzelura) has shown good efficacy in the treatment of skin diseases, patients should pay close attention to the occurrence of side effects during use. Any abnormal reactions should be communicated to the doctor promptly to ensure safe and effective treatment.